This is an open-label extension study to evaluate the safety of continued therapy with inhaled Treprostinil in patients with pulmonary hypertension due to chronic obstructive pulmonary disease (COPD) in participants who have completed Study RIN-PH-304 

Please use this link for further information:

clinicaltrials.gov